Sex hormone associations with breast cancer risk and the mediation of randomized trial postmenopausal hormone therapy effects.

scientific article

Sex hormone associations with breast cancer risk and the mediation of randomized trial postmenopausal hormone therapy effects. is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1018625764
P356DOI10.1186/BCR3632
P932PMC publication ID4053241
P698PubMed publication ID24670297
P5875ResearchGate publication ID261137481

P50authorJoAnn E. MansonQ6204013
Lewis KullerQ88077314
Rowan T ChlebowskiQ89795128
Garnet L AndersonQ37387870
Shanshan ZhaoQ61832423
P2093author name stringRoss L Prentice
Jacques E Rossouw
Sayeh Lavasani
Dorothy S Lane
Thomas E Rohan
Margery Gass
Ruth Patterson
Shirley Aa Beresford
P2860cites workRisks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trialQ27860743
Classification and pharmacology of progestinsQ28244614
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trialQ29615226
The effects of postmenopausal hormone therapy on serum estrogen, progesterone, and sex hormone-binding globulin levels in healthy postmenopausal womenQ33838504
Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized TrialQ34208463
The Women's Health Initiative recruitment methods and resultsQ34272010
Scientific rationale for postmenopause delay in the use of conjugated equine estrogens among postmenopausal women that causes reduction in breast cancer incidence and mortalityQ34362281
Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy.Q34512916
Breast cancer risk in relation to the interval between menopause and starting hormone therapyQ34577224
Breast cancer after use of estrogen plus progestin in postmenopausal womenQ34938322
Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trialQ36143058
Estrogen plus progestin therapy and breast cancer in recently postmenopausal womenQ37163009
Sex hormone levels and risk of breast cancer with estrogen plus progestinQ37209551
Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational studyQ37245244
Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in Postmenopausal WomenQ37480990
Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trialsQ37658616
Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study GroupQ39513392
Design of the Women’s Health Initiative Clinical Trial and Observational StudyQ56483522
Implementation of the women's health initiative study designQ57055364
Projecting individualized probabilities of developing breast cancer for white females who are being examined annuallyQ69396132
Outcomes ascertainment and adjudication methods in the women's health initiativeQ79202519
P275copyright licenseCreative Commons Attribution 2.0 GenericQ19125117
P6216copyright statuscopyrightedQ50423863
P433issue2
P304page(s)R30
P577publication date2014-03-26
P1433published inBreast Cancer ResearchQ2208481
P1476titleSex hormone associations with breast cancer risk and the mediation of randomized trial postmenopausal hormone therapy effects
P478volume16

Reverse relations

cites work (P2860)
Q30980873Breast Cancer After Use of Estrogen Plus Progestin and Estrogen Alone: Analyses of Data From 2 Women's Health Initiative Randomized Clinical Trials.
Q30843682Covariate measurement error correction methods in mediation analysis with failure time data.
Q30238978Long-term hormone therapy for perimenopausal and postmenopausal women
Q34315478Menopausal hormone therapy and cancer: changing clinical observations of target site specificity
Q37351543Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials
Q91637842Study on the Antibreast Cancer Mechanism and Bioactive Components of Si-Wu-Tang by Cell Type-Specific Molecular Network
Q90661837The modulation of estrogen-induced apoptosis as an interpretation of the women's health initiative trials

Search more.